investorscraft@gmail.com

Intrinsic ValueMacromill, Inc. (3978.T)

Previous Close¥1,274.00
Intrinsic Value
Upside potential
Previous Close
¥1,274.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Macromill, Inc. operates as a specialized provider of marketing research and digital marketing solutions, leveraging advanced neuroresearch techniques to analyze consumer behavior beyond traditional surveys. The company's core offerings include Internet and offline research, digital marketing analytics, and data-driven advertising services, positioning it at the intersection of neuroscience and marketing intelligence. Its proprietary tools, such as Movie Karte for video ad effectiveness and Macromill Ads for digital campaign optimization, differentiate it in the competitive advertising agency sector. With a strong foothold in Japan and collaborations like its partnership with Sumitomo Mitsui Card Co., Macromill combines scientific rigor with scalable digital solutions to serve global clients. The company’s focus on high-value, data-centric services allows it to cater to industries requiring deep consumer insights, including healthcare and e-commerce. Its ability to integrate neuroresearch with traditional and digital marketing methodologies reinforces its niche leadership and adaptability in a rapidly evolving market.

Revenue Profitability And Efficiency

Macromill reported revenue of ¥43.9 billion for FY 2024, with net income of ¥2.3 billion, reflecting a net margin of approximately 5.2%. Operating cash flow stood at ¥8.3 billion, supported by efficient working capital management. Capital expenditures were modest at ¥307 million, indicating a capital-light model focused on scalable digital services rather than heavy infrastructure investments.

Earnings Power And Capital Efficiency

The company’s diluted EPS of ¥59.86 underscores its earnings capability, though its beta of 0.395 suggests lower volatility relative to the market. With a debt-to-equity ratio influenced by ¥33.1 billion in total debt against ¥10.4 billion in cash, Macromill’s capital structure leans moderately leveraged, but its stable cash flows mitigate refinancing risks.

Balance Sheet And Financial Health

Macromill maintains a liquidity buffer with ¥10.4 billion in cash and equivalents, though its total debt of ¥33.1 billion warrants monitoring. The balance sheet reflects a focus on growth financing, with manageable leverage given its consistent operating cash generation. The absence of significant capex demands supports financial flexibility.

Growth Trends And Dividend Policy

The company’s growth is tied to demand for data-driven marketing solutions, with dividends of ¥15 per share signaling a commitment to shareholder returns. Its market cap of ¥48.9 billion implies investor confidence in its niche positioning, though top-line expansion will depend on adoption of its neuroresearch and digital ad tools in new markets.

Valuation And Market Expectations

Trading at a market cap of ¥48.9 billion, Macromill’s valuation reflects its specialized capabilities in neuroresearch and digital marketing. The low beta suggests defensive positioning, while the P/E ratio derived from its EPS indicates moderate growth expectations. Its collaboration-driven model may unlock further upside if partnerships expand globally.

Strategic Advantages And Outlook

Macromill’s integration of neuroscience with marketing analytics provides a durable edge in an increasingly data-centric industry. Its partnerships and scalable digital offerings position it well for cross-border growth, though competition from larger ad networks remains a challenge. The outlook hinges on leveraging its technological differentiation while maintaining profitability in a fragmented sector.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount